Advertisement

Topics

Latest "Aphton Corporation" News Stories

22:53 EDT 23rd May 2018 | BioPortfolio

Here are the most relevant search results for "Aphton Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Aphton Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Aphton Corporation for you to read. Along with our medical data and news we also list Aphton Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Aphton Corporation Companies for you to search.

Showing "Aphton Corporation" News Articles 1–25 of 277

Wednesday 23rd May 2018

NuCana Reports First Quarter 2018 Financial Results

EDINBURGH, United Kingdom, May  23, 2018  (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients, announced financial results for the first quarter ended March 31, 2018. As of March 31, 2018, NuCana had cash and cash equivalents of £81.3 million compared to £18.3 million a...


Monday 21st May 2018

International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018

CARLSBAD, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update announcing operating results for the three months ended March 31, 2018. “This...

Friday 18th May 2018

BK Ultrasound, Powered by Analogic, Launches bkSpecto Ultrasound System for Urology at the 2018 American Urological Association Annual Meeting

PEABODY, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, today announced that it will launch the bkSpecto(TM) ultrasound system at the 113th AUA (American Urological Association) Annual Meeting, May 18-21, in San Francisco. bkSpecto-taken from the Latin word Specto, meaning 'I see&...


Thursday 17th May 2018

Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer

Novartis International AG / Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Results from the Kisqali® MONALEESA clinical trial program, the largest industry- sponsored Phase III registration program researching...

Tuesday 15th May 2018

International Endeavors Corporation, a Medical Marijuana IP Holdings Company Announces Revolutionary Canna Power Transportable Microgrid (CPTM)

Earth Friendly Grid Independent Power Systems Transportable Power System

Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists

Sunnyvale, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company scored 100% on clinical laboratory proficiency testing conducted by the College of American Pathologists (CAP).  Arrayit received a perfect score in highly quantitative measurements of immunoglobulin E (IgE), the antibodies in the human ...

Novartis successfully completes acquisition of AveXis, Inc.

Novartis International AG / Novartis successfully completes acquisition of AveXis, Inc. . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. The digital press release with multimedia content can be accessed here: 

CEL-SCI Corporation Reports Second Quarter Fiscal 2018 Financial Results

CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended March 31, 2018. The Company also reported key clinical and corporate developments achieved during the quarter. Clinical and Corporate Developments included: CEL-SCI’s Phase 3 head and neck cancer study has been fully enrolled since...

Aradigm Announces First Quarter 2018 Financial Results

Aradigm Corporation (NASDAQ: ARDM) (the “Company”) today announced financial results for the first quarter and three months ended March 31, 2018. First Quarter 2018 Financial Results The Company recorded $1.5 million in revenue in the first quarter of 2018 compared with $1.7 million in revenue in the first quarter of 2017. The ...

Novartis completes tender offer for all outstanding shares of AveXis, Inc.

Novartis International AG / Novartis completes tender offer for all outstanding shares of AveXis, Inc. . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, May 15, 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced the successful completion of the previously announced tender of...

Monday 14th May 2018

Bovie Medical Corporation Reports First Quarter 2018 Financial Results; Reaffirms Fiscal Year 2018 Financial Outlook

Advanced Energy Sales of $2.6 million in Q1, up 333% year-over-year Bovie Medical Corporation (NYSEMKT:BVX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market, today reported financial r...

Astrotech Reports Third Quarter of Fiscal Year 2018 Financial Results

Astrotech Corporation (NASDAQ:ASTC) reported its financial results for the third quarter of fiscal year 2018 ended March 31, 2018. “In the third quarter, we made progress at 1st Detect, announcing two key milestones regarding our newly developed TRACER 1000, which detects trace amounts of military, commercial, and homemade explosives, plus narco...

Sunday 13th May 2018

International Stem Cell Corporation is Valued at $34 Million Market Value by Edison Investment Research

CARLSBAD, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that it has been valued at $34 million, up from $33 million in January 2018, by Edison Investment Research ("Edison")*, a world-re...

International Endeavors Corporation, a Medical Marijuana IP Holdings Company, Secures a $500,000 Investment Commitment From Voltage River

TEMECULA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation, a Medical Marijuana IP Holdings Company, today announces that the Company has received an investment commitment of $500,000 from its strategic partner Voltage River (www.voltageriver.com). The capital injection will be used primarily for expanding the production of the Company’s newest p...

Wednesday 9th May 2018

Geron Corporation Reports First Quarter 2018 Financial Results

MENLO PARK, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2018. First Quarter 2018 Results For the first quarter of 2018, the company reported operating revenues of $318,000 and operating expenses of $7.8 million compared to $537,000 and $8.0 million, respectively, for the comparable 2017 period...

Quorum Health Corporation Announces First Quarter 2018 Financial and Operating Results

Quorum Health Corporation (NYSE: QHC) (the “Company”) today announced its financial and operating results for the three months ended March 31, 2018. First Quarter 2018 Financial and Operating Results The Company’s financial and operating results for the three months ended March 31, 2018 reflect the following: ...

Glaukos Corporation Announces First Quarter 2018 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced financial results for the first quarter ended March 31, 2018. Key highlights include:...

20152023 World Reverse Osmosis Membrances Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 12022018] Prices from USD $2800

SummaryxxxThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Ame...

STERIS Announces Changes to Board of Directors

John P. Wareham to retire as Chairman and Board member at the Company's 2018 Annual General Meeting of Shareholders Dr. Mohsen M. Sohi, independent Board member since 2005, expected to be appointed as Chairman Company appoints Dr. Nirav Shah to Board of Directors DERBY, U.K.  - (May 9, 2018) - STERIS plc (NYSE: STE) ("STERIS" or the "Company") today ann...

STERIS Announces Financial Results for Fiscal 2018 Fourth Quarter and Full Year

Fourth quarter revenue increases 5% both on an as reported and constant currency organic basis Fourth quarter earnings improve to $0.86 per diluted share as reported; adjusted earnings per diluted share increases 12% to $1.24 Full year fiscal 2018 earnings grow to $3.39 per diluted share as reported; adjusted earnings per diluted share increases 10% to $4.15 Fiscal 2019 expected t...

Tuesday 8th May 2018

Arrayit Corporation Announces New Clinical Licensure from the Centers for Medicare and Medicaid Services

Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid Services (CMS), which oversees the Clinical Laboratory Improvement Amendments (CLIA) Program.  Arrayit’s new CLIA license, issued in conjunction with the Department of Health an...

Prothena Reports First Quarter 2018 Financial Results and Provides R&D Update

Net cash used in operating and investing activities was $31.8 million in the first quarter; quarter-end cash and restricted cash position of $433.1 million supports advancement through key milestones of R&D pipeline Entered into global neuroscience research & development collaboration with Celgene to advance novel therapies for patients with neurodegenerative diseases Initiated a f...

Quidel Reports First Quarter 2018 Financial Results

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2018. First Quarter 2018 Highlights Total revenue was $169.1 million as compared to $73.7 million in the ...

Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä

ORION CORPORATION         MANAGERS' TRANSACTIONS 8 MAY 2018 at 16.30 EETS Orion Corporation: Managers' transactions - Eero Karvonen kuolinpesä Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associ...

Monday 7th May 2018

Invacare Reports Results for First Quarter 2018

Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended March 31, 2018. Highlights Reported net sales increased 2.3% to $237.1 million while constant currency net sales(a) decreased 4.4% compared to 1Q17*. Constant currency sequential net sales(b) decreased 6.6...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks